티디에스팜

464280· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩5,370+9.59%

2026-08-04

Financials

Valuation Metrics

티디에스팜's Market Cap is ₩297B. At end of 2025 it was ₩545B. Ranked #2108 of 2,436 in KR market (top 87%), #1347 of 1,649 on KOSDAQ (top 82%), #218 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 93%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	29.70B KRW	KR#2,108/2,436 Sec#218/234
Revenue	30.41B KRW	KR#2,024/2,436 Sec#140/234
Net Income	5.05B KRW	KR#1,124/2,436 Sec#75/234
Total Assets	62.01B KRW	KR#2,064/2,436 Sec#180/234
Net Assets	43.93B KRW	KR#1,964/2,436 Sec#169/234
Value
P/E	5.88x	KR#339/2,436 Sec#12/234
P/B	0.68x	KR#1,054/2,436 Sec#52/234
PEG	0.03x	KR#167/2,436 Sec#7/234
P/S	0.98x	KR#1,344/2,436 Sec#78/234
EV/EBITDA	8.17x	KR#447/2,436 Sec#16/234
Profitability
ROE	11.51%	KR#410/2,436 Sec#26/234
ROA	8.15%	KR#325/2,436 Sec#24/234
Op. Margin	16.18%	KR#240/2,436 Sec#22/234
Revenue Growth	52.87%	KR#283/2,436 Sec#30/234
Earnings Growth	212.91%	KR#236/2,436 Sec#16/234
Financial Health
Debt Ratio	141.15%	KR#1,064/2,436 Sec#122/234
Total Debt	13.80B KRW	KR#1,507/2,436 Sec#135/234
Cash	3.30B KRW	KR#2,133/2,436 Sec#199/234
Current Ratio	2.09x	KR#898/2,436 Sec#103/234
Net Debt/EBITDA	2.13x	KR#903/2,436 Sec#65/234
Performance
1Y Return	-49.29%	KR#2,106/2,436 Sec#198/234
1M Return	-14.35%	KR#2,123/2,436 Sec#202/234
From 52W High	-53.91%	KR#1,491/2,436 Sec#122/234
1Y MDD	-60.41%	KR#1,433/2,436 Sec#115/234
Trading
Volume	22,078 shares	KR#1,942/2,436 Sec#190/234
Foreign Own.	3.35%	KR—/2,436 Sec—/234
Per Share
EPS	914 KRW	KR#657/2,436 Sec#45/234
BPS	8,307 KRW	KR#1,056/2,436 Sec#74/234